Jazz Pharmaceuticals plc (JAZZ) › Shareholders' EquityJazz Pharmaceuticals plc (JAZZ) — Shareholders' EquityAnnual figures by period end, from SEC filings.2008-12-31: -$92.88M2009-12-31: -$72.83M2010-12-31: $30.55M2011-12-31: $192.79M2012-12-31: $1.12B2013-12-31: $1.30B2014-12-31: $1.37B2015-12-31: $1.60B2016-12-31: $1.88B2017-12-31: $2.71B2018-12-31: $2.76B2019-12-31: $3.11B2020-12-31: $3.66B2021-12-31: $3.97B2022-12-31: $3.09B2023-12-31: $3.74B2024-12-31: $4.09B2025-12-31: $4.32B$4.32B2008-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$4.32B+5.5%2026-02-24Balance as of period end2024-12-31$4.09B+9.5%2026-02-24Balance as of period end2023-12-31$3.74B+21.1%2026-02-24Balance as of period end2022-12-31$3.09B-22.2%2026-02-24Balance as of period end2021-12-31$3.97B+8.3%2025-02-26Balance as of period end2020-12-31$3.66B+17.6%2024-02-28Balance as of period end2019-12-31$3.11B+12.8%2023-03-01Balance as of period end2018-12-31$2.76B+1.6%2022-03-01Balance as of period end2017-12-31$2.71B+44.5%2021-02-23Balance as of period end2016-12-31$1.88B+17.4%2020-02-25Balance as of period end2015-12-31$1.60B+16.6%2016-02-23Balance as of period end2014-12-31$1.37B+5.8%2016-02-23Balance as of period end2013-12-31$1.30B+15.5%2015-02-24Balance as of period end2012-12-31$1.12B+481.6%2014-02-25Balance as of period end2011-12-31$192.79M+531.0%2014-02-25Balance as of period end2010-12-31$30.55M—2014-02-25Balance as of period end2009-12-31-$72.83M—2013-02-26Balance as of period end2008-12-31-$92.88M—2012-02-28Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)